CVS Health (CVS Health) Cash And Cash Equivalents

: $8,196 Mil (As of Dec. 2023)

View and export this data going back to 1952. Start your Free Trial

CVS Health's quarterly cash and cash equivalents declined from Jun. 2023 ($13,807.00 Mil) to Sep. 2023 ($13,043.00 Mil) but then stayed the same from Sep. 2023 ($13,043.00 Mil) to Dec. 2023 ($8,196.00 Mil).

CVS Health's annual cash and cash equivalents increased from Dec. 2021 ($9,408.00 Mil) to Dec. 2022 ($12,945.00 Mil) but then declined from Dec. 2022 ($12,945.00 Mil) to Dec. 2023 ($8,196.00 Mil).

CVS Health Cash And Cash Equivalents Historical Data

The historical data trend for CVS Health's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVS Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

5,683.00

7,854.00

9,408.00

12,945.00

8,196.00

CVS Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents																12,945.00	14,618.00	13,807.00	13,043.00	8,196.00

CVS Health Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

CVS Health (NYSE:CVS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

CVS Health Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of CVS Health's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

CVS Health (CVS Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (NYSE:CVS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

CVS:Peru CVS:Mexico 1CVS:Italy CVSd:UK CVS0:Germany CVS:Germany CVS:Germany CVS:Germany CVS:Chile CVS:Canada CVSH34:Brazil CVS:Austria

Address

One CVS Drive, Woonsocket, RI, USA, 02895

Website

https://www.cvshealth.com

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

Executives

Edward J Ludwig	director	C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Michael F Mahoney	director	BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Thomas F. Cowhey	officer: SVP, Interim CFO	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
J Scott Kirby	director	233 S. WACKER DRIVE 11TH FL WHQLD, CHICAGO IL 60606
Brian A Kane	officer: EVP/President, Aetna	500 W MAIN STREET, LOUISVILLE KY 40202
James David Clark	officer: SVP, Cont & Chief Acct Officer	ONE CVS DRIVE, WOONSOCKET RI 02760
Karen S Lynch	officer: EVP & Pres, Aetna Bus Unit	151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Samrat S. Khichi	officer: EVP, CPO and General Counsel	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Thomas M Moriarty	officer: EVP & General Counsel	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey R. Balser	director	3657 RICHLAND AVE., NASHVILLE TN 37205
Alan Lotvin	officer: EVP, Transformation	55 NOD ROAD, AVON CT 06001
Daniel P Finke	officer: EVP/Pres, Health Care Benefits	ONE CVS DRIVE, WOONSOCKET RI 02895
Tilak Mandadi	officer: EVP, Chief Technology Officer	3600 LAS VEGAS BLVD. SOUTH, LAS VEGAS NV 89109
Sreekanth K Chaguturu	officer: EVP and Chief Medical Officer	ONE CVS DRIVE, WOONSOCKET RI 02895
Prem S Shah	officer: EVP and Co-President of Retail	ONE CVS DRIVE, WOONSOCKET RI 02895